Samar Alhomoud

1.5k total citations
35 papers, 1.1k citations indexed

About

Samar Alhomoud is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Samar Alhomoud has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Samar Alhomoud's work include Colorectal Cancer Screening and Detection (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Colorectal Cancer Surgical Treatments (9 papers). Samar Alhomoud is often cited by papers focused on Colorectal Cancer Screening and Detection (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Colorectal Cancer Surgical Treatments (9 papers). Samar Alhomoud collaborates with scholars based in Saudi Arabia, United States and Egypt. Samar Alhomoud's co-authors include Nasser Al‐Sanea, Luai H. Ashari, Alaa Abduljabbar, Fouad Al‐Dayel, Khawla S. Al‐Kuraya, Prashant Bavi, Shahab Uddin, Jehad Abubaker, Maqbool Ahmed and Denise Hibbert and has published in prestigious journals such as Cancer Research, Oncogene and Gut.

In The Last Decade

Samar Alhomoud

35 papers receiving 1.1k citations

Peers

Samar Alhomoud

ONCOL

PFM

PRM

Nasser Al‐Sanea Saudi Arabia

Cletus A. Arciero United States

Neal Osborn United States

Celina Ang United States

Tatsu Shimoyama Japan

Henrik Hellborg Sweden

K. Gunnarsdóttir Denmark

Muhammad Salim United States

Dennie V. Jones United States

Pierre Chan Hong Kong

Nasser Al‐Sanea Saudi Arabia

Samar Alhomoud

549 ×0.9

ONCOL

493 ×1.1

383 ×1.3

PFM

267 ×1.2

193 ×1.0

PRM

Citations per year, relative to Samar Alhomoud Samar Alhomoud (= 1×) peers Nasser Al‐Sanea

Countries citing papers authored by Samar Alhomoud

Since Specialization

Citations

This map shows the geographic impact of Samar Alhomoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Alhomoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Alhomoud more than expected).

Fields of papers citing papers by Samar Alhomoud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Alhomoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Alhomoud. The network helps show where Samar Alhomoud may publish in the future.

Co-authorship network of co-authors of Samar Alhomoud

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Alhomoud. A scholar is included among the top collaborators of Samar Alhomoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Alhomoud. Samar Alhomoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alhomoud, Samar, et al.. (2022). Progress and remaining challenges for cancer control in the Gulf Cooperation Council. The Lancet Oncology. 23(11). e493–e501. 15 indexed citations

Masoodi, Tariq, Abdul K. Siraj, Saud Azam, et al.. (2020). Clonal Evolution and Timing of Metastatic Colorectal Cancer. Cancers. 12(10). 2938–2938. 8 indexed citations

Siraj, Abdul K., Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.. (2019). TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC. Molecular Cancer Therapeutics. 18(7). 1312–1322. 19 indexed citations

Gunter, Marc J., Samar Alhomoud, Melina Arnold, et al.. (2019). Meeting report from the joint IARC–NCI international cancer seminar series: a focus on colorectal cancer. Annals of Oncology. 30(4). 510–519. 51 indexed citations

Abduljabbar, Alaa, et al.. (2018). Dose Escalation with Simultaneous Integrated Boost (SIB) Using Volumetric Modulated Arc Therapy (VMAT) in Rectal Cancer. Journal of Gastrointestinal Cancer. 50(4). 735–739. 4 indexed citations

Fadhil, Ibtihal & Samar Alhomoud. (2018). Colorectal Screening Programs in Gulf Countries: The Role of Primary Care. Journal of Global Oncology. 4(Supplement 2). 36s–36s. 4 indexed citations

Siraj, Abdul K., Tariq Masoodi, Rong Bu, et al.. (2017). MED12is recurrently mutated in Middle Eastern colorectal cancer. Gut. 67(4). gutjnl–2016. 13 indexed citations

Siraj, Abdul K., Tariq Masoodi, Rong Bu, et al.. (2017). Expanding the spectrum of germline variants in cancer. Human Genetics. 136(11-12). 1431–1444. 24 indexed citations

Bazarbashi, Shouki, Ahmad Alzahrani, Nasser Al‐Sanea, et al.. (2016). Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer. Hematology/Oncology and Stem Cell Therapy. 9(4). 147–153. 6 indexed citations

10.

Hibbert, Denise, Alaa Abduljabbar, Samar Alhomoud, Luai H. Ashari, & Nasser Al‐Sanea. (2015). Risk Factors for Abdominal Incision Infection after Colorectal Surgery in a Saudi Arabian Population: The Method of Surveillance Matters. Surgical Infections. 16(3). 254–262. 6 indexed citations

11.

Uddin, Shahab, Maqbool Ahmed, Azhar Hussain, et al.. (2011). Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy. American Journal Of Pathology. 178(2). 537–547. 131 indexed citations

12.

Uddin, Shahab, Azhar Hussain, Maqbool Ahmed, et al.. (2011). Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma. American Journal Of Pathology. 179(6). 3032–3044. 8 indexed citations

13.

Bavi, Prashant, Shahab Uddin, Maqbool Ahmed, et al.. (2011). Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma. American Journal Of Pathology. 178(5). 2109–2120. 53 indexed citations

14.

Bavi, Prashant, Sarita Prabhakaran, Jehad Abubaker, et al.. (2010). Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations. Molecular Cancer. 9(1). 203–203. 21 indexed citations

15.

Uddin, Shahab, Prashant Bavi, Azhar R. Hussain, et al.. (2009). Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis. 30(11). 1832–1840. 53 indexed citations

16.

Jehan, Zeenath, Prashant Bavi, Mehar Sultana, et al.. (2009). Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. The Journal of Pathology. 219(3). 337–346. 48 indexed citations

17.

Uddin, Shahab, Maqbool Ahmed, Prashant Bavi, et al.. (2008). Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer. Cancer Research. 68(9). 3379–3388. 66 indexed citations

18.

Uddin, Shahab, Maqbool Ahmed, Prashant Bavi, et al.. (2008). Bortezomib(Velcade) induces p27kip1 associated cell cycle arrest and apoptosis through down-regulation of SKP2 ubiquitin ligase pathway in colorectal carcinoma. Cancer Research. 68. 3265–3265. 1 indexed citations

19.

Abubaker, Jehad, Prashant Bavi, Sayer Al-harbi, et al.. (2008). Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene. 27(25). 3539–3545. 79 indexed citations

20.

Abubaker, Jehad, Prashant Bavi, Sayer Al-harbi, et al.. (2007). Clinicopathological analysis of colorectal cancers withPIK3CA mutations in Middle Eastern population. Molecular Cancer Therapeutics. 6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact